Copyright Reports & Markets. All rights reserved.

Global Brucellosis Vaccines Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Brucellosis Vaccines Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Brucellosis Vaccines Market Size Growth Rate by Type
    • 1.2.2 S19 Vaccine
    • 1.2.3 RB51 Vaccine Strain
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Brucellosis Vaccines Market Size Growth Rate by Application
    • 1.3.2 Cattle
    • 1.3.3 Sheep
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Brucellosis Vaccines Market Size Estimates and Forecasts
    • 2.1.1 Global Brucellosis Vaccines Revenue 2015-2026
    • 2.1.2 Global Brucellosis Vaccines Sales 2015-2026
  • 2.2 Brucellosis Vaccines Market Size by Region: 2020 Versus 2026
  • 2.3 Brucellosis Vaccines Sales by Region (2015-2026)
    • 2.3.1 Global Brucellosis Vaccines Sales by Region: 2015-2020
    • 2.3.2 Global Brucellosis Vaccines Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Brucellosis Vaccines Sales Market Share by Region (2015-2026)
  • 2.4 Brucellosis Vaccines Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Brucellosis Vaccines Revenue by Region: 2015-2020
    • 2.4.2 Global Brucellosis Vaccines Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Brucellosis Vaccines Revenue Market Share by Region (2015-2026)

3 Global Brucellosis Vaccines by Manufacturers

  • 3.1 Global Top Brucellosis Vaccines Manufacturers by Sales
    • 3.1.1 Global Brucellosis Vaccines Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Brucellosis Vaccines Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Brucellosis Vaccines Manufacturers by Revenue
    • 3.2.1 Global Brucellosis Vaccines Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Brucellosis Vaccines Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Brucellosis Vaccines Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Brucellosis Vaccines Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Brucellosis Vaccines Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Brucellosis Vaccines Manufacturing Base Distribution, Product Type
    • 3.5.1 Brucellosis Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Brucellosis Vaccines Product Type
    • 3.5.3 Date of International Manufacturers Enter into Brucellosis Vaccines Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 Jinyu
    • 4.1.1 Jinyu Corporation Information
    • 4.1.2 Jinyu Description, Business Overview
    • 4.1.3 Jinyu Brucellosis Vaccines Products Offered
    • 4.1.4 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 Jinyu Brucellosis Vaccines Revenue by Product
    • 4.1.6 Jinyu Brucellosis Vaccines Revenue by Application
    • 4.1.7 Jinyu Brucellosis Vaccines Revenue by Geographic Area
    • 4.1.8 Jinyu Brucellosis Vaccines Revenue by Sales Channel
    • 4.1.9 Jinyu Recent Development
  • 4.2 Colorado Serum
    • 4.2.1 Colorado Serum Corporation Information
    • 4.2.2 Colorado Serum Description, Business Overview
    • 4.2.3 Colorado Serum Brucellosis Vaccines Products Offered
    • 4.2.4 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 Colorado Serum Brucellosis Vaccines Revenue by Product
    • 4.2.6 Colorado Serum Brucellosis Vaccines Revenue by Application
    • 4.2.7 Colorado Serum Brucellosis Vaccines Revenue by Geographic Area
    • 4.2.8 Colorado Serum Brucellosis Vaccines Revenue by Sales Channel
    • 4.2.9 Colorado Serum Recent Development
  • 4.3 Boehringer Ingelheim
    • 4.3.1 Boehringer Ingelheim Corporation Information
    • 4.3.2 Boehringer Ingelheim Description, Business Overview
    • 4.3.3 Boehringer Ingelheim Brucellosis Vaccines Products Offered
    • 4.3.4 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 Boehringer Ingelheim Brucellosis Vaccines Revenue by Product
    • 4.3.6 Boehringer Ingelheim Brucellosis Vaccines Revenue by Application
    • 4.3.7 Boehringer Ingelheim Brucellosis Vaccines Revenue by Geographic Area
    • 4.3.8 Boehringer Ingelheim Brucellosis Vaccines Revenue by Sales Channel
    • 4.3.9 Boehringer Ingelheim Recent Development
  • 4.4 Biogenesis-Bago
    • 4.4.1 Biogenesis-Bago Corporation Information
    • 4.4.2 Biogenesis-Bago Description, Business Overview
    • 4.4.3 Biogenesis-Bago Brucellosis Vaccines Products Offered
    • 4.4.4 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Biogenesis-Bago Brucellosis Vaccines Revenue by Product
    • 4.4.6 Biogenesis-Bago Brucellosis Vaccines Revenue by Application
    • 4.4.7 Biogenesis-Bago Brucellosis Vaccines Revenue by Geographic Area
    • 4.4.8 Biogenesis-Bago Brucellosis Vaccines Revenue by Sales Channel
    • 4.4.9 Biogenesis-Bago Recent Development
  • 4.5 Vetal Company
    • 4.5.1 Vetal Company Corporation Information
    • 4.5.2 Vetal Company Description, Business Overview
    • 4.5.3 Vetal Company Brucellosis Vaccines Products Offered
    • 4.5.4 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 Vetal Company Brucellosis Vaccines Revenue by Product
    • 4.5.6 Vetal Company Brucellosis Vaccines Revenue by Application
    • 4.5.7 Vetal Company Brucellosis Vaccines Revenue by Geographic Area
    • 4.5.8 Vetal Company Brucellosis Vaccines Revenue by Sales Channel
    • 4.5.9 Vetal Company Recent Development
  • 4.6 CZ Veterinaria
    • 4.6.1 CZ Veterinaria Corporation Information
    • 4.6.2 CZ Veterinaria Description, Business Overview
    • 4.6.3 CZ Veterinaria Brucellosis Vaccines Products Offered
    • 4.6.4 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 CZ Veterinaria Brucellosis Vaccines Revenue by Product
    • 4.6.6 CZ Veterinaria Brucellosis Vaccines Revenue by Application
    • 4.6.7 CZ Veterinaria Brucellosis Vaccines Revenue by Geographic Area
    • 4.6.8 CZ Veterinaria Recent Development
  • 4.7 SYVA Laboratorios
    • 4.7.1 SYVA Laboratorios Corporation Information
    • 4.7.2 SYVA Laboratorios Description, Business Overview
    • 4.7.3 SYVA Laboratorios Brucellosis Vaccines Products Offered
    • 4.7.4 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 SYVA Laboratorios Brucellosis Vaccines Revenue by Product
    • 4.7.6 SYVA Laboratorios Brucellosis Vaccines Revenue by Application
    • 4.7.7 SYVA Laboratorios Brucellosis Vaccines Revenue by Geographic Area
    • 4.7.8 SYVA Laboratorios Recent Development
  • 4.8 Indian Immunologicals
    • 4.8.1 Indian Immunologicals Corporation Information
    • 4.8.2 Indian Immunologicals Description, Business Overview
    • 4.8.3 Indian Immunologicals Brucellosis Vaccines Products Offered
    • 4.8.4 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.8.5 Indian Immunologicals Brucellosis Vaccines Revenue by Product
    • 4.8.6 Indian Immunologicals Brucellosis Vaccines Revenue by Application
    • 4.8.7 Indian Immunologicals Brucellosis Vaccines Revenue by Geographic Area
    • 4.8.8 Indian Immunologicals Recent Development
  • 4.9 Qilu
    • 4.9.1 Qilu Corporation Information
    • 4.9.2 Qilu Description, Business Overview
    • 4.9.3 Qilu Brucellosis Vaccines Products Offered
    • 4.9.4 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.9.5 Qilu Brucellosis Vaccines Revenue by Product
    • 4.9.6 Qilu Brucellosis Vaccines Revenue by Application
    • 4.9.7 Qilu Brucellosis Vaccines Revenue by Geographic Area
    • 4.9.8 Qilu Recent Development
  • 4.10 Tecnovax
    • 4.10.1 Tecnovax Corporation Information
    • 4.10.2 Tecnovax Description, Business Overview
    • 4.10.3 Tecnovax Brucellosis Vaccines Products Offered
    • 4.10.4 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.10.5 Tecnovax Brucellosis Vaccines Revenue by Product
    • 4.10.6 Tecnovax Brucellosis Vaccines Revenue by Application
    • 4.10.7 Tecnovax Brucellosis Vaccines Revenue by Geographic Area
    • 4.10.8 Tecnovax Recent Development
  • 4.11 Hester Biosciences
    • 4.11.1 Hester Biosciences Corporation Information
    • 4.11.2 Hester Biosciences Description, Business Overview
    • 4.11.3 Hester Biosciences Brucellosis Vaccines Products Offered
    • 4.11.4 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.11.5 Hester Biosciences Brucellosis Vaccines Revenue by Product
    • 4.11.6 Hester Biosciences Brucellosis Vaccines Revenue by Application
    • 4.11.7 Hester Biosciences Brucellosis Vaccines Revenue by Geographic Area
    • 4.11.8 Hester Biosciences Recent Development
  • 4.12 Zoetis
    • 4.12.1 Zoetis Corporation Information
    • 4.12.2 Zoetis Description, Business Overview
    • 4.12.3 Zoetis Brucellosis Vaccines Products Offered
    • 4.12.4 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.12.5 Zoetis Brucellosis Vaccines Revenue by Product
    • 4.12.6 Zoetis Brucellosis Vaccines Revenue by Application
    • 4.12.7 Zoetis Brucellosis Vaccines Revenue by Geographic Area
    • 4.12.8 Zoetis Recent Development
  • 4.13 Onderstepoort Biological
    • 4.13.1 Onderstepoort Biological Corporation Information
    • 4.13.2 Onderstepoort Biological Description, Business Overview
    • 4.13.3 Onderstepoort Biological Brucellosis Vaccines Products Offered
    • 4.13.4 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.13.5 Onderstepoort Biological Brucellosis Vaccines Revenue by Product
    • 4.13.6 Onderstepoort Biological Brucellosis Vaccines Revenue by Application
    • 4.13.7 Onderstepoort Biological Brucellosis Vaccines Revenue by Geographic Area
    • 4.13.8 Onderstepoort Biological Recent Development
  • 4.14 Instituto Rosenbusch
    • 4.14.1 Instituto Rosenbusch Corporation Information
    • 4.14.2 Instituto Rosenbusch Description, Business Overview
    • 4.14.3 Instituto Rosenbusch Brucellosis Vaccines Products Offered
    • 4.14.4 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.14.5 Instituto Rosenbusch Brucellosis Vaccines Revenue by Product
    • 4.14.6 Instituto Rosenbusch Brucellosis Vaccines Revenue by Application
    • 4.14.7 Instituto Rosenbusch Brucellosis Vaccines Revenue by Geographic Area
    • 4.14.8 Instituto Rosenbusch Recent Development
  • 4.15 Ceva Sante Animale
    • 4.15.1 Ceva Sante Animale Corporation Information
    • 4.15.2 Ceva Sante Animale Description, Business Overview
    • 4.15.3 Ceva Sante Animale Brucellosis Vaccines Products Offered
    • 4.15.4 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.15.5 Ceva Sante Animale Brucellosis Vaccines Revenue by Product
    • 4.15.6 Ceva Sante Animale Brucellosis Vaccines Revenue by Application
    • 4.15.7 Ceva Sante Animale Brucellosis Vaccines Revenue by Geographic Area
    • 4.15.8 Ceva Sante Animale Recent Development
  • 4.16 Calier & Biologicos Laverlam
    • 4.16.1 Calier & Biologicos Laverlam Corporation Information
    • 4.16.2 Calier & Biologicos Laverlam Description, Business Overview
    • 4.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Products Offered
    • 4.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.16.5 Calier & Biologicos Laverlam Brucellosis Vaccines Revenue by Product
    • 4.16.6 Calier & Biologicos Laverlam Brucellosis Vaccines Revenue by Application
    • 4.16.7 Calier & Biologicos Laverlam Brucellosis Vaccines Revenue by Geographic Area
    • 4.16.8 Calier & Biologicos Laverlam Recent Development
  • 4.17 Biovet
    • 4.17.1 Biovet Corporation Information
    • 4.17.2 Biovet Description, Business Overview
    • 4.17.3 Biovet Brucellosis Vaccines Products Offered
    • 4.17.4 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 4.17.5 Biovet Brucellosis Vaccines Revenue by Product
    • 4.17.6 Biovet Brucellosis Vaccines Revenue by Application
    • 4.17.7 Biovet Brucellosis Vaccines Revenue by Geographic Area
    • 4.17.8 Biovet Recent Development

5 Breakdown Data by Type

  • 5.1 Global Brucellosis Vaccines Sales by Type (2015-2026)
    • 5.1.1 Global Brucellosis Vaccines Sales by Type (2015-2020)
    • 5.1.2 Global Brucellosis Vaccines Sales Forecast by Type (2021-2026)
    • 5.1.3 Global Brucellosis Vaccines Sales Market Share by Type (2015-2026)
  • 5.2 Global Brucellosis Vaccines Revenue Forecast by Type (2015-2026)
    • 5.2.1 Global Brucellosis Vaccines Revenue by Type (2015-2020)
    • 5.2.2 Global Brucellosis Vaccines Revenue Forecast by Type (2021-2026)
    • 5.2.3 Global Brucellosis Vaccines Revenue Market Share by Type (2015-2026)
  • 5.3 Brucellosis Vaccines Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

  • 6.1 Global Brucellosis Vaccines Sales by Application (2015-2026)
    • 6.1.1 Global Brucellosis Vaccines Sales by Application (2015-2020)
    • 6.1.2 Global Brucellosis Vaccines Sales Forecast by Application (2021-2026)
    • 6.1.3 Global Brucellosis Vaccines Sales Market Share by Application (2015-2026)
  • 6.2 Global Brucellosis Vaccines Revenue Forecast by Application (2015-2026)
    • 6.2.1 Global Brucellosis Vaccines Revenue by Application (2015-2020)
    • 6.2.2 Global Brucellosis Vaccines Revenue Forecast by Application (2021-2026)
    • 6.2.3 Global Brucellosis Vaccines Revenue Market Share by Application (2015-2026)
  • 6.3 Brucellosis Vaccines Average Selling Price (ASP) by Application (2015-2026)

7 North America

  • 7.1 North America Brucellosis Vaccines Market Size YoY Growth 2015-2026
  • 7.2 North America Brucellosis Vaccines Market Facts & Figures by Country
    • 7.2.1 North America Brucellosis Vaccines Sales by Country (2015-2026)
    • 7.2.2 North America Brucellosis Vaccines Revenue by Country (2015-2026)
  • 7.3 North America Brucellosis Vaccines Sales by Type
  • 7.4 North America Brucellosis Vaccines Sales by Application

8 Asia-Pacific

  • 8.1 Asia-Pacific Brucellosis Vaccines Market Size YoY Growth 2015-2026
  • 8.2 Asia-Pacific Brucellosis Vaccines Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Brucellosis Vaccines Sales by Region (2015-2026)
    • 8.2.2 Asia-Pacific Brucellosis Vaccines Revenue by Region (2015-2026)
  • 8.3 Asia-Pacific Brucellosis Vaccines Sales by Type
  • 8.4 Asia-Pacific Brucellosis Vaccines Sales by Application

9 Europe

  • 9.1 Europe Brucellosis Vaccines Market Size YoY Growth 2015-2026
  • 9.2 Europe Brucellosis Vaccines Market Facts & Figures by Country
    • 9.2.1 Europe Brucellosis Vaccines Sales by Country (2015-2026)
    • 9.2.2 Europe Brucellosis Vaccines Revenue by Country (2015-2026)
  • 9.3 Europe Brucellosis Vaccines Sales by Type
  • 9.4 Europe Brucellosis Vaccines Sales by Application

10 Latin America

  • 10.1 Latin America Brucellosis Vaccines Market Size YoY Growth 2015-2026
  • 10.2 Latin America Brucellosis Vaccines Market Facts & Figures by Country
    • 10.2.1 Latin America Brucellosis Vaccines Sales by Country (2015-2026)
    • 10.2.2 Latin America Brucellosis Vaccines Revenue by Country (2015-2026)
  • 10.3 Latin America Brucellosis Vaccines Sales by Type
  • 10.4 Latin America Brucellosis Vaccines Sales by Application

11 Middle East and Africa

  • 11.1 Middle East and Africa Brucellosis Vaccines Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Brucellosis Vaccines Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Brucellosis Vaccines Sales by Country (2015-2026)
    • 11.2.2 Middle East and Africa Brucellosis Vaccines Revenue by Country (2015-2026)
  • 11.3 Middle East and Africa Brucellosis Vaccines Sales by Type
  • 11.4 Middle East and Africa Brucellosis Vaccines Sales by Application

12 Supply Chain and Sales Channel Analysis

  • 12.1 Brucellosis Vaccines Supply Chain Analysis
  • 12.2 Brucellosis Vaccines Key Raw Materials and Upstream Suppliers
  • 12.3 Brucellosis Vaccines Clients Analysis
  • 12.4 Brucellosis Vaccines Sales Channel and Sales Model Analysis
    • 12.4.1 Brucellosis Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.4.2 Brucellosis Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.4.3 Brucellosis Vaccines Distributors

13 Market Dynamics

  • 13.1 Brucellosis Vaccines Market Drivers
  • 13.2 Brucellosis Vaccines Market Opportunities
  • 13.3 Brucellosis Vaccines Market Challenges
  • 13.4 Brucellosis Vaccines Market Restraints
  • 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Brucellosis Vaccines market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Brucellosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

    Segment by Type, the Brucellosis Vaccines market is segmented into
    S19 Vaccine
    RB51 Vaccine Strain
    Other

    Segment by Application, the Brucellosis Vaccines market is segmented into
    Cattle
    Sheep
    Other

    Regional and Country-level Analysis:
    North America
    United States
    Canada
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Southeast Asia
    Australia
    Rest of Asia-Pacific
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic Countries
    Rest of Europe
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    Competitive Landscape and Brucellosis Vaccines Market Share Analysis
    Brucellosis Vaccines market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Brucellosis Vaccines product introduction, recent developments, Brucellosis Vaccines sales by region, type, application and by sales channel.

    The major companies include:
    Jinyu
    Colorado Serum
    Boehringer Ingelheim
    Biogenesis-Bago
    Vetal Company
    CZ Veterinaria
    SYVA Laboratorios
    Indian Immunologicals
    Qilu
    Tecnovax
    Hester Biosciences
    Zoetis
    Onderstepoort Biological
    Instituto Rosenbusch
    Ceva Sante Animale
    Calier & Biologicos Laverlam
    Biovet

    Buy now